Anti-Platelet drugs in the Anti-thrombotic drug segment had a market value of over 13 billion Indian rupees that year. Anti-coagulants followed with over 10 billion Indian rupees. Anti-thrombotic drugs had a market value of over 25 billion Indian rupees in financial year 2020 in India.
Value of anti-thrombotic market across India in financial year 2020, by drug class (in million Indian rupees)
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Cardiovascular disease in India
Overview
5
- Premium Statistic Deaths caused by chronic diseases 2019
- Basic Statistic Prevalence of select risk factors in cardiovascular disease deaths worldwide in 2016
- Basic Statistic Market share of cardiac market India FY 2020, by drug type
- Basic Statistic Market share of cardiac sales India FY 2020, by leading company
- Basic Statistic Penetrated market share in cardiac segment India FY 2020, by leading company
Heart disease
5
- Premium Statistic Share of people with heart problems India 2020, by age group
- Premium Statistic Share of people with cholesterol and heart problems India 2020, by gender
- Premium Statistic Risk of heart problems India 2019 by body mass index
- Premium Statistic Impact of cholesterol on heart issues among Indians 2019
- Premium Statistic Number of cases of heart disease in senior citizens India 2011-2050
Hypertension
4
- Premium Statistic Number of cases of hypertension in senior citizens India 2011-2050
- Premium Statistic Chronic disease incidence to treatment India 2019, by disease type
- Basic Statistic Value of hypertension market India FY 2020, by drug class
- Basic Statistic Share of hypertension market India FY 2020, by drug class
Leading cardiac therapies
4
- Basic Statistic Share of hypertension market India FY 2020, by drug class
- Basic Statistic Value of hyperlipidemia market India FY 2020, by drug class
- Basic Statistic Value of hypertension market India FY 2020, by drug class
- Basic Statistic Value of anti-thrombotic market India FY 2020, by drug class
Leading cardiac brands and molecules
7
- Basic Statistic Market value of leading brand in the cardiac segment India FY 2020
- Basic Statistic Market value of leading molecules in the cardiac segment India FY 2020
- Basic Statistic Market value of leading fastest growing molecules in cardiac segment India FY 2020
- Basic Statistic Number of one billion rupee brands in the cardiac segment India FY 2016-2020
- Basic Statistic Number of 500 million rupee brands in the cardiac segment India FY 2016-2020
- Basic Statistic Share of top five molecules in cardiac therapy India FY 2016-2020
- Basic Statistic Share of top ten molecules in cardiac therapy India FY 2016-2020
Leading market players
7
- Basic Statistic Glenmark Pharma' share of cardiac in IPM FY 2011-20
- Basic Statistic JB Chemicals' share of cardiac in IPM FY 2011-20
- Basic Statistic Dr.Reddy's laboratories' share of cardiac in Indian pharmaceutical market FY 2011-20
- Basic Statistic Cipla's share of cardiac in Indian pharmaceutical market FY 2011-2020
- Basic Statistic Lupin's share of cardiac in Indian pharmaceutical market FY 2011-2020
- Basic Statistic Torrent Pharmaceutical share of cardiac in Indian pharmaceutical market FY 2011-2020
- Basic Statistic Sun Pharmaceuticals' share of cardiac in Indian pharmaceutical market FY 2011-2020
Further related statistics
15
- Public drug program spending in Canada by top 10 drug classes 2022
- Private sector funded drug spending Canada by top drug classes share 2013
- Expected growth in U.S. pharma profit 2019-2024 by drug type
- Public drug program spending share for seniors in Canada by top drug classes 2022
- Share of Russians purchasing medications 2019, by type
- Public drug program spending for non-seniors in Canada by top drug classes 2022
- Drug cost distribution by drug type in public drug plans Canada 2021/2022
- Drug price changes in the U.S. by product group until end-2019
- Global osteoporosis drug market size from 2014 to 2022, by drug type
- Public drug program spending in Canada by top drug classes 2022
- Annual moving revenue pharmaceutical market India 2018 by segment
- Revenue of German pharmacies by drug category 2022
- Rate of U.S. averse drug events in hospitals 2014, by drug type
- Rate of U.S. averse drug events that originated in hospital in 2014, by drug type
- Global osteoporosis drug market share 2014-2022, by drug type
Further Content: You might find this interesting as well
Statistics
- Public drug program spending in Canada by top 10 drug classes 2022
- Private sector funded drug spending Canada by top drug classes share 2013
- Expected growth in U.S. pharma profit 2019-2024 by drug type
- Public drug program spending share for seniors in Canada by top drug classes 2022
- Share of Russians purchasing medications 2019, by type
- Public drug program spending for non-seniors in Canada by top drug classes 2022
- Drug cost distribution by drug type in public drug plans Canada 2021/2022
- Drug price changes in the U.S. by product group until end-2019
- Global osteoporosis drug market size from 2014 to 2022, by drug type
- Public drug program spending in Canada by top drug classes 2022
- Annual moving revenue pharmaceutical market India 2018 by segment
- Revenue of German pharmacies by drug category 2022
- Rate of U.S. averse drug events in hospitals 2014, by drug type
- Rate of U.S. averse drug events that originated in hospital in 2014, by drug type
- Global osteoporosis drug market share 2014-2022, by drug type
HDFC Securities. (September 29, 2020). Value of anti-thrombotic market across India in financial year 2020, by drug class (in million Indian rupees) [Graph]. In Statista. Retrieved May 15, 2024, from https://www.statista.com/statistics/1201967/india-value-of-anti-thrombotic-market-by-drug-class/
HDFC Securities. "Value of anti-thrombotic market across India in financial year 2020, by drug class (in million Indian rupees)." Chart. September 29, 2020. Statista. Accessed May 15, 2024. https://www.statista.com/statistics/1201967/india-value-of-anti-thrombotic-market-by-drug-class/
HDFC Securities. (2020). Value of anti-thrombotic market across India in financial year 2020, by drug class (in million Indian rupees). Statista. Statista Inc.. Accessed: May 15, 2024. https://www.statista.com/statistics/1201967/india-value-of-anti-thrombotic-market-by-drug-class/
HDFC Securities. "Value of Anti-thrombotic Market across India in Financial Year 2020, by Drug Class (in Million Indian Rupees)." Statista, Statista Inc., 29 Sep 2020, https://www.statista.com/statistics/1201967/india-value-of-anti-thrombotic-market-by-drug-class/
HDFC Securities, Value of anti-thrombotic market across India in financial year 2020, by drug class (in million Indian rupees) Statista, https://www.statista.com/statistics/1201967/india-value-of-anti-thrombotic-market-by-drug-class/ (last visited May 15, 2024)
Value of anti-thrombotic market across India in financial year 2020, by drug class (in million Indian rupees) [Graph], HDFC Securities, September 29, 2020. [Online]. Available: https://www.statista.com/statistics/1201967/india-value-of-anti-thrombotic-market-by-drug-class/